Chinese robotics startup Dexmal is seeking a valuation of about 20 billion yuan (roughly $3 billion) in an ongoing funding round, according to multiple reports. The company develops embodied artificial intelligence intended to help robots perform real-world tasks, with the fundraising talks still in progress.
The outlets describe Dexmal as part of a broader push by investors and companies in China to back “physical” or embodied AI—systems designed to control robots rather than only analyze digital data. Bloomberg frames the effort as reflecting strong investor interest in firms pursuing a breakthrough in this area. PYMNTS adds detail that Dexmal founder Tang Wenbin says discussions are ongoing and notes that Alibaba Group has previously led rounds that involve the startup.
While both sources align on the target valuation and the fact that talks are underway, they mainly differ in emphasis: Bloomberg highlights the funding as a sign of market interest in embodied AI, while PYMNTS focuses on the company’s AI-robot mission and the founder’s comment that the round is still being negotiated.
